Business

Brazilian women to take Bayer to court over Essure side effects

Over 300 women plan to launch a class action for damages from the pharmaceutical giant, complaining that they developed severe complications after implanting Bayer's permanent contraceptive Essure

Brazilian women to take Bayer to court over Essure side effects
Bayer headquarters in Berlin. Photo: Hinterhof/Shutterstock

In 2019, multinational pharmaceutical firm Bayer took its permanent birth control device Essure off the market in Brazil amid a slew of complaints from women who suffered severe complications after use.

Consisting of a pair of metal coils implanted into each fallopian tube, Essure functions as a method of permanent sterilization by inducing fibrosis and creating blockages, stopping eggs from being released, and keeping sperm from reaching the ovules. Bayer stresses that its “innovative” product is safe, yet a high number of users in Brazil, the U.S., and Europe have developed intense pain and severe complications after receiving...

Access all of The Brazilian Report
Start your 7-day free trial.
Free trial